Summary
The effects of the angiotensin converting enzyme inhibitor lisinopril on slow and fast twitch muscle contractile properties, nerve conduction and hypoxic resistance, and muscle and nerve capillary density were examined in streptozotocin-diabetic rats. Prolongation of soleus contraction and relaxation were partially prevented by treatment (p<0.01). A 22% deficit in fast twitch extensor digitorum longus tetanic tension production was also ameliorated (p<0.01). Sciatic motor and sensory conduction velocity, 25% and 12% reduced by diabetes respectively, were 75% normalized by lisinopril (p<0.01). There was a 47% increase in resistance to hypoxic conduction block with diabetes (p<0.01). Lisinopril treatment resulted in normal hypoxic resistance. Capillarisation of nerve and muscle was little affected by diabetes; however, there was a 17% increase in capillary density in sciatic nerve, and a 40% increase in extensor digitorum longus muscle with lisinopril (p<0.01). For soleus, a smaller treatment-induced increase in capillary density led to an elevated capillary/muscle fibre ratio (p<0.01). These results suggest that lisinopril promoted angiogenesis. It was concluded that the beneficial effect of preventive lisinopril treatment is likely to depend upon a reduction of peripheral vascular resistance and improvement of tissue blood flow, which implicates relative hypoxia as an important factor in the development of myopathy and neuropathy in experimental diabetes.
Article PDF
Similar content being viewed by others
References
Low PA, Tuck RR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 266–278
Lattimer SA, Sima AAF, Greene DA (1989) In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists. Am J Physiol 256: E264-E269
Mayer JH, Tomlinson DR (1983) Prevention of defects in axonal transport and nerve conduction by oral administration of myoinositol or an aldose reductase inhibitor in streptozotocindiabetic rats. Diabetologia 25: 433–438
Cameron NE, Leonard MB, Ross IS, Whiting PH (1986) The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat. Diabetologia 29: 168–174
Cameron NE, Cotter MA, Robertson S (1989) The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q J Exp Physiol 74: 917–926
Yasuda H, Sonobe M, Yamashita M et al. (1989) Effect of prostaglandin ei analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats, comparison with aldose reductase inhibitor ONO 2235. Diabetes 38: 832–838
Sima AAF, Bril V, Nathaniel V et al. (1988) Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 319: 548–555
Ward KK, Low PA, Schmelzer JD, Zochodne DW (1989) Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112: 197–208
Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. Br Med J 293: 1053–1054
Cameron NE, Cotter MA, Robertson S (1989) Chronic low frequency electrical activation for one week corrects nerve conduction deficits in rats with diabetes of three months duration. Diabetologia 32: 759–761
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 26: E1-E8
Tilton RG, Chang K, Pugliese G et al. (1989) Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 38: 1258–1270
Cotter MA, Cameron NE, Lean D, Robertson S (1989) Effects of long-term streptozotocin diabetes on the contractile and histochemical properties of rat muscles. Q J Exp Physiol 74: 65–74
Cameron NE, Cotter MA, Robertson S (1989) Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition. Diabetologia 32: 365–370
Cameron NE, Cotter MA, Robertson S (1990) Changes in skeletal muscle contractile properties in streptozocin-induced diabetic rats and role of polyol pathway and hypoinsulinemia. Diabetes 39: 460–465
Robertson S (1989) Changes in skeletal muscle contractile properties in rats fed a dietary galactose supplement. J Physiol (Lond) 409: 76P (Abstract)
Rosen R, Beck E, Rosen P (1988) Early vascular alterations in the diabetic rat heart. Acta Physiol Hung 72: 3–11
Rosen P, Rosen R, Hohl C, Reinauer H, Klaus W (1984) Reduced transcoronary exchange and prostaglandin synthesis in diabetic rat heart. Am J Physiol 247: H563-H567
Monfano WM, Eliasson SG, Shimazaki S, Sugimoto H (1988) Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol 99: 607–614
Yagi S, Takata S, Kiyokawa H, et al. (1988) Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 37: 1064–1067
Hudlicka O, Tyler KR (1986) Angiogenesis: the growth of the vascular system. Academic Press, New York
Sweet CS, Ulm EH (1988) Lisinopril. Cardiovasc drug reviews 6: 181–191
Cameron NE, Cotter MA, Robertson S (1991) Effects of essential fatty acid dietary supplementation on peripheral nerve and skeletal muscle function and capillarization in streptozocin diabetic rats. Diabetes 40: 532–539
Ziada AMAR, Hudlicka O, Tyler KR, Wright AJA (1984) The effect of long term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 18: 724–732
Stribling D, Mirrless DJ, Harrison HE, Earl DCN (1985) Properties of ICI 128436, a novel aldose reductase inhibitor and its effects on diabetic complications in the rat. Metabolism 34: 336–344
Duncan DB (1955) Multiple range and multiple F tests. Biometrics 11: 1–42
Kramer CY (1956) Extension of multiple range tests to group means with unequal numbers of replications. Biometrics 12: 307–310
Seneviratne KN, Peiris OA (1969) The effects of hypoxia on the excitability of the isolated peripheral nerves of alloxan-diabetic rats. J Neurol Neurosurg Psychiat 32: 462–469
Paulus SF, Grossie J (1983) Skeletal muscle in alloxan diabetes. A comparison of isometric contractions in fast and slow muscle. Diabetes 32: 1035–1039
Zochodne DW, Ward K, Low PA (1988) Guanethidine adrenergic neuropathy: an animal model of selective autonomic neuropathy. Brain Res 461: 10–16
Zochodne DW, Huang Z, Ward K, Low PA (1990) Guanethidine adrenergic sympathectomy augments endoneurial perfusion and lowers endoneurial microvascular resistance. Brain Res 519: 112–117
Tomlinson DR, Robinson JP, Compton AM, Keen P (1989) Essential fatty acid treatment — effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 32: 655–659
Afzal N, Ganguly PK, Dhalla KS, Pierce GN, Singal PK, Dhalla NS (1988) Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37: 936–942
Eibschutz B, Lopaschuk GD, McNeill JH, Katz S (1984) Ca2+ transport in skeletal muscle sarcoplasmic reticulum of the chronically diabetic rat. Res Commun Chem Pathol Pharmacol 45: 301–304
Chao TT, Ianuzzo CD, Armstrong RB, Albright JT, Anapolle SE (1976) Ultrastructural alterations in skeletal muscle fibres of streptozotocin-diabetic rats. Cell Tiss Res 168: 239–246
Rot DM, Reibel DK, Lefer AM (1983) Vascular responsiveness and eicosanoid production in diabetic rats. Diabetologia 24: 372–376
Cameron NE, Cotter MA, Robertson S (1987) Effects of experimental diabetes on contractile properties of skeletal muscles of the rat and the effect of treatment with the aldose reductase inhibitor Statil (ICI 128436). J Physiol (Lond) 387:43 P (Abstract)
Bowers WD, Burlington RF, Whitten BK, Daum RC, Posiviata MA (1971) Ultrastructural and metabolic alterations in myocardium from altitude-acclimated rats. Am J Physiol 220: 1885–1889
Maher JT, Goodman AL, Bowers WD, Hartley LH, Angelakos ET (1972) Myocardial function and ultrastructure in chronically hypoxic rats. Am J Physiol 223: 1029–1033
Mcgrath JJ, Bullard RW, Komives GK (1969) Functional adaptation in cardiac and skeletal muscle after exposure to simulated high altitude. Fed Proc 28: 1307–1311
Folkow B, Halicka HD (1968) A comparison between “red” and “white” muscle with respect to blood supply, capillary surface area and oxygen uptake during rest and exercise. Microvasc Res 1: 1–14
Scarborough NL, Carrier GO (1983) Increased alpha2-adrenoreceptor mediated vascular contraction in diabetic rats. J Autonom Pharmacol 3: 177–183
Morff RJ (1990) Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozocin-induced diabetes. Diabetes 39: 354–360
Davidson WS, Murphy DG (1985) Aldehyde reductases and their involvement in muscular dystrophy. In: Flynn G (ed) Enzymology of carbonyl metabolism 2: aldehyde dehydrogenase, aldo-keto reductase and alcohol dehydrogenase. A R Liss Inc., New York, pp 251–263
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cameron, N.E., Cotter, M.A. & Robertson, S. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35, 12–18 (1992). https://doi.org/10.1007/BF00400846
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400846